{"disease":{"id":"alzheimer-type-dementia","name":"alzheimer type dementia"},"drugs":{"marketed":[{"drug_id":"donepezil","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aricept","generic_name":"DONEPEZIL","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":"800","mechanism":"Aricept works by blocking the enzyme that breaks down a key neurotransmitter in the brain, acetylcholine."},{"drug_id":"donepezil-aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Donepezil (Aricept)","company_name":"University of Virginia","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"Acetylcholinesterase Inhibitor","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aricept","company_name":"Eisai Korea Inc.","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"namenda","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Namenda","company_name":"Inova Health Care Services","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"memantine","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Namenda","generic_name":"MEMANTINE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glutamate NMDA receptor; GRIN1/GRIN2A","drug_class":"N-methyl-D-aspartate Receptor Antagonist","quality_score":60,"revenue":null,"mechanism":"Namenda works by blocking the action of glutamate at the NMDA receptor, reducing excessive neural activity associated with Alzheimer's disease."},{"drug_id":"ebixa","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ebixa","company_name":"Konkuk University Medical Center","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04680013","title":"Genetic Studies in Familial Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":4884,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT07016178","title":"Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research","phase":"NA","overall_status":"COMPLETED","enrollment_count":3454,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT05052450","title":"Factors Associated With Mortality, Morbidity and Prognosis in Dementia Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Gulhane Training and Research Hospital","has_results":false},{"nct_id":"NCT05923307","title":"Multifactorial Approach to Dementia, Multicentric Study","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"Daniel Serrani Azcurra","has_results":false},{"nct_id":"NCT04428112","title":"Rural Dementia Caregiver Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":418,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT07115251","title":"Plans4Care: Personalized Dementia Care on Demand","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Plans4Care Inc","has_results":false},{"nct_id":"NCT03732053","title":"The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Universidad Católica San Antonio de Murcia","has_results":false},{"nct_id":"NCT05860127","title":"Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"University of Massachusetts, Amherst","has_results":true},{"nct_id":"NCT03333837","title":"Improvisational Movement for People With Memory Loss and Their Caregivers","phase":"NA","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT03672266","title":"Studies of Brain and Body Interaction","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rutgers University","has_results":false},{"nct_id":"NCT05643144","title":"Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes","phase":"NA","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT06898424","title":"Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Prof. Lutfu Hanoglu, MD","has_results":false},{"nct_id":"NCT05524181","title":"Telehealth-enabled Integrated Palliative Care for People With Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT04828434","title":"Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05040321","title":"Sirtuin-NAD Activator in Alzheimer's Disease","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06378372","title":"How Does Pianistic Musical Training Influence the Development of Alzheimer's Disease?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"David Franco Castellanos","has_results":false},{"nct_id":"NCT06718686","title":"Rifaximin SSD in Dementia Trial","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Jasmohan Bajaj","has_results":false},{"nct_id":"NCT04313582","title":"Feasibility of the SmartPrompt for Improving Everyday Function in Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT06965062","title":"Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Vincent Tay Khwee Soon","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}